Manulife (Manufacturers Life Insurance)
LBRX

Manulife (Manufacturers Life Insurance)’s LB Pharmaceuticals LBRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,488
Closed -$276K – 2976
2025
Q3 		$276K Buy
+17,488
New +$277K ﹤0.01% 2426

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Manulife (Manufacturers Life Insurance)'s LBRX Position: Q4 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of LB Pharmaceuticals (LBRX) in Q4 2025, closing a stake of 17,488 shares — an estimated $276K sold.

Manulife (Manufacturers Life Insurance) first reported a position in LBRX in Q3 2025 and held it in 1 quarter. The position peaked at $276K in Q3 2025. 68 funds tracked by Wall St. Rank hold LBRX as of Q4 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining LB Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 17,488 LB Pharmaceuticals shares in Q4 2025, an estimated $276K.
  • Manulife (Manufacturers Life Insurance) first reported a position in LB Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s LB Pharmaceuticals position peaked at $276K in Q3 2025.
  • 68 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q4 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2025, filed 13 Feb 2026.